Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

Bone Marrow Transplantation

Volumn 17, Issue 3, 1996, Pages 365-369

  Dunlop, L C ^a   Powles, R ^a   Singhal, S ^a   Treleaven, J G ^a   Swansbury, G J ^a   Meller, S ^a   Pinkerton, C R ^a   Horton, C ^a   Mehta, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acute lymphoblastic leukaemia; Allogeneic bone marrow transplantation; Autologous bone marrow transplantation; Immunotherapy; Interferon ; Peripheral blood stem cell transplantation; Philadelphia chromosome

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER STAGING; CLINICAL ARTICLE; DEATH; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LEUKEMIA REMISSION; MALE; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SCHOOL CHILD; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029863613     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Preti A, Kantarjian HM. Management of adult acute lymphoblastic leukemia: present issues and key challenges. J Clin Oncol 1994; 12: 1312-1322.
2. Bloomfield CD, Goldman AI, Alimena G et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 1986; 67: 415-420.
3. Fletcher JA, Lynch EA, Kimball VM et al. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435-439.
4. Kantarjian HM. Talpaz M, Dhingra K et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411-2418.
5. Annino L, Ferrari A, Cedrone M et al. Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period. Leukemia 1994; 8: 664-667.
6. Grigg AP. Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1993; 12: 431-435.
7. Arlin ZA, Feldman EJ, Ahmed T et al. Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukaemia (ALL) is resistant to effective therapy for Phi-negative ALL. Acta Haematol 1989; 81: 217-218.
8. Roberts WM, Rivera GK, Raimondi SC et al. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet 1994; 343: 331-332.
9. Forman SJ, O'Donnell MR, Nademanee AP et al. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 587-588.
10. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
11. Miyamura K, Tanimoto M, Morishima Y et al. Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood 1992; 79: 1366-1370.
12. Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
13. Mehta J, Powles R, Singhal S et al. Sequential high-dose therapy of adult acute lymphoblastic leukemia: role of maintenance chemotherapy after peripheral blood stem cell transplantation in first remission. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation. Proc Seventh Int Symp, Arlington, TX. The Cancer Treatment Research and Educational Institute: Arlington, 1995, pp 135-144.
14. Tiley C. Powles R, Treleaven J et al. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leu-kaemia. Bone Marrow Transplant 1993: 12: 449-455.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1955; 53: 457-481.
16. Chao NJ, Blume KG, Forman SJ, Snyder DS. Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1995; 85: 3353-3354.
17. Arnold R. Heyll A. Kolb JH et al. BMT in Ph1 positive ALL after intensified chemotherapy according to the German multicentre studies for adult ALL. Bone Marrow Transplant 1995; 15 (Suppl. 2): S71 (abstr.).
18. Stockschläder M, Hegewisch S, Krüger W et al. Outcome of 14 patients with Philadelphia-chromosome-positive ALL receiving autologous or allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15 (Suppl. 2): S71 (abstr.).
19. Gehly GB, Bryant EM. Lee AM et al. Chimeric BCR-ABL messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1991; 78: 458-465.
20. Durrant IJ, Prentice HG, Richards SM. MRC UKALL XA. The UK randomised clinical trial in adult ALL: 1985-1992. Br J Haematol 1994; 87 (Suppl. 1): 8.
21. Mehta J, Powles R, Singhal S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
22. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994; 330: 820-825.
23. Ohyashiki K, Ohyashiki JH, Toyama K. Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts. Leuk Lymphoma 1993; 9: 43-48.
24. Mehta J. Graft-versus-Ieukemia reactions in clinical bone marrow transplantation. Leuk Lymphoma 1993; 10: 427-432.
25. Meyers JD, Flournoy N, Sanders JE et al. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 1987; 107: 809-816.
26. Mehta J, Powles R, Singhal S et al. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 133-137.
27. Mehta J, Powles R, Treleaven J et al. Melphalan versus cyclophosphamide with total body irradiation as conditioning for allogeneic bone marrow transplantation in first remission acute myeloid leukemia. Blood 1994; 84 (Suppl. 1): 714a.